Hospital
Mary Black Health System LLC
Mary Black Health System LLC was paid $2.31M by Medicaid between Jan 2018 and Dec 2018, across 143 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 28% of everything it billed.
33Billing provider infoMARY BLACK HEALTH SYSTEM LLC
SPARTANBURG, SC 29307
SPARTANBURG, SC 29307
33aNPI1669425963assigned 05/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.31M
24GClaims85,457
24DCodes billed143
24AFirst – last monthJan 2018 – Dec 2018
Compared with peers
Next to other General Acute Care Hospital providers in South Carolina
Rank by total paid#60 of 115
Median peer was paid$2.47M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 85,457 | $2.31M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 28% | 5,890 | 4,792 | $648K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12% | 2,709 | 2,500 | $279K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.7% | 928 | 863 | $154K |
| 87430 | 6.1% | 1,681 | 1,563 | $140K | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.5% | 5,847 | 5,280 | $128K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.2% | 915 | 253 | $51K |
| 82962 | 2.0% | 1,094 | 577 | $46K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.0% | 551 | 502 | $45K |
| 81001 | 1.9% | 4,081 | 3,591 | $44K | |
| 71046 | Radiologic examination, chest; 2 views | 1.9% | 1,911 | 1,733 | $43K |
| 81025 | 1.9% | 2,042 | 1,843 | $43K | |
| 87400 | 1.7% | 2,151 | 1,461 | $40K |
131 more codes
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.7% | 115 | $39K |
| 99284 | Emergency room visit (serious) | 1.6% | 3,484 | $38K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.5% | 630 | $35K |
| 87070 | 1.4% | 201 | $32K | |
| 87420 | 1.2% | 445 | $28K | |
| 73630 | 1.1% | 210 | $25K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.0% | 1,144 | $23K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.0% | 623 | $23K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.0% | 819 | $23K |
| 59025 | Fetal non-stress test | <1% | 388 | $23K |
| 73610 | <1% | 190 | $22K | |
| 84702 | <1% | 596 | $18K | |
| 73562 | <1% | 203 | $16K | |
| 87186 | <1% | 516 | $16K | |
| 93971 | <1% | 90 | $14K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,739 | $13K |
| 86850 | <1% | 303 | $13K | |
| 74018 | <1% | 459 | $13K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 88 | $13K |
| 73130 | <1% | 102 | $12K | |
| 72100 | <1% | 253 | $11K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 76 | $11K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 351 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 783 | $10K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 277 | $10K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 202 | $9K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 166 | $9K |
| 73030 | <1% | 117 | $9K | |
| 73110 | <1% | 59 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,393 | $8K |
| 81003 | <1% | 470 | $7K | |
| 10060 | <1% | 44 | $6K | |
| 76830 | Ultrasound, transvaginal | <1% | 141 | $6K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 29 | $5K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 175 | $5K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $5K |
| 84112 | <1% | 39 | $5K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 16 | $5K |
| 80306 | <1% | 470 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 516 | $4K |
| 72050 | <1% | 58 | $4K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,706 | $4K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 131 | $4K |
| G0378 | Hospital observation service, per hour | <1% | 270 | $3K |
| 99285 | Emergency room visit (most serious) | <1% | 1,038 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 182 | $3K |
| 87210 | <1% | 541 | $3K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 245 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 997 | $2K |
| 87081 | <1% | 210 | $2K | |
| 87077 | <1% | 213 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 740 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,135 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 266 | $2K |
| 74022 | <1% | 156 | $2K | |
| 83880 | <1% | 279 | $2K | |
| 97161 | <1% | 46 | $2K | |
| 76642 | <1% | 42 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 295 | $1K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 468 | $1K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 561 | $979.33 |
| 85379 | <1% | 323 | $966.61 | |
| 86901 | <1% | 649 | $962.41 | |
| 86738 | <1% | 347 | $890.86 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 280 | $704.46 |
| 87088 | <1% | 410 | $645.79 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 226 | $644.06 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 17 | $555.84 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 713 | $552.67 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 631 | $552.66 |
| 77065 | Tomosynthesis, mammo | <1% | 13 | $546.04 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 17 | $497.84 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 118 | $485.24 |
| 12001 | <1% | 27 | $476.42 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 49 | $392.98 |
| 84484 | <1% | 1,231 | $392.12 | |
| 97597 | <1% | 63 | $374.54 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 775 | $307.11 |
| 85027 | <1% | 608 | $280.87 | |
| 82553 | <1% | 714 | $256.95 | |
| 83605 | <1% | 297 | $244.75 | |
| 97162 | <1% | 14 | $238.37 | |
| 82272 | <1% | 17 | $210.18 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 789 | $161.72 |
| 80061 | Lipid panel | <1% | 64 | $140.13 |
| 74021 | <1% | 27 | $136.72 | |
| 88304 | <1% | 58 | $126.59 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,120 | $114.35 |
| 84550 | <1% | 32 | $112.03 | |
| 84703 | <1% | 179 | $65.97 | |
| 87040 | <1% | 482 | $13.84 | |
| J2704 | Injection, propofol, 10 mg | <1% | 592 | $9.73 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 211 | $8.12 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,763 | $4.88 |
| 83690 | <1% | 1,251 | $4.05 | |
| 86900 | <1% | 649 | $3.69 | |
| 82009 | 0% | 31 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 149 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 159 | $0.00 |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | 0% | 48 | $0.00 |
| 85610 | 0% | 468 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 139 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 157 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 108 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 16 | $0.00 |
| 90715 | 0% | 13 | $0.00 | |
| 82570 | 0% | 14 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 394 | $0.00 |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 0% | 13 | $0.00 |
| 86140 | 0% | 154 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 552 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 0% | 506 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 456 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 226 | $0.00 |
| 71275 | Computed tomographic angiography, chest, with contrast material | 0% | 95 | $0.00 |
| 83735 | 0% | 610 | $0.00 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 235 | $0.00 |
| 82550 | 0% | 784 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 234 | $0.00 |
| 85730 | 0% | 264 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 42 | $0.00 |
| 96376 | 0% | 90 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 748 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 432 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 19 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 26 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 71 | $0.00 |
| 85652 | 0% | 40 | $0.00 | |
| 94760 | 0% | 63 | $0.00 | |
| 80349 | 0% | 15 | $0.00 | |
| 86308 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIREDTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.